New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - octocog alfa 2000 [iu];   - injection with diluent - 2000 iu - active: octocog alfa 2000 [iu]   excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - advate is indicated for use in haemophilia a for prevention and control of haemorrhagic episodes. patients with haemophilia a may be treated with advate as perioperative management. advate is not indicated in von willebrand's disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - efmoroctocog alfa 2000 [iu];   - powder for infusion - 2000 iu - active: efmoroctocog alfa 2000 [iu]   excipient: calcium chloride dihydrate histidine polysorbate 20 sodium chloride sucrose water for injection - eloctate is a long-acting antihaemophilic factor (recombinant) indicated in adults and children with haemophilia a (congenital factor viii deficiency) for: · control and prevention of bleeding episodes · routine prophylaxis to prevent or reduce the frequency of bleeding episodes · perioperative management (surgical prophylaxis). eloctate does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand's disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - octocog alfa 2000 [iu] (recombinant factor viii) - injection with diluent - 2000 iu - active: octocog alfa 2000 [iu] (recombinant factor viii) excipient: calcium chloride glycine histidine polysorbate 80 sodium chloride sucrose water for injection water for injection - kogenate fs is indicated in congenital factor viii deficiency (haemophilia a) for the treatment and prophylaxis of bleeding in untreated and previously treated patients without inhibitors.

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - epoetin beta 2000 [iu] (in 0.3ml) - solution for injection - 2000 iu/0.3ml - active: epoetin beta 2000 [iu] (in 0.3ml) excipient: calcium chloride dihydrate dibasic sodium phosphate dodecahydrate glutamic acid glycine isoleucine leucine monobasic sodium phosphate dihydrate phenylalanine polysorbate 20 sodium chloride threonine urea water for injection - - for the treatment of anaemia associated with chronic kidney disease in patients on dialysis and symptomatic patients not yet undergoing dialysis - for the prevention of anaemia of prematurity in infants with a birth weight of 750 g to 1500 g and a gestational age of less than 34 weeks - for the treatment of anaemia in patients with non-myeloid malignancies, where anaemia develops as a result of concomitantly administered chemotherapy, and where blood transfusion is not considered appropriate. - to increase the yield of autologous blood from patients in a pre-donation programme initiated to avoid the use of homologous blood

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - moroctocog alfa 2000 [iu] equivalent to 180 µg;   - injection with diluent - 2000 iu - active: moroctocog alfa 2000 [iu] equivalent to 180 µg   excipient: calcium chloride dihydrate histidine polysorbate 80 sodium chloride sucrose sodium chloride water for injection - xyntha is indicated for the control and prevention of haemorrhagic episodes in patients with haemophilia a, including control and prevention of bleeding in surgical settings. xyntha does not contain von willebrand factor and should not be used by patients with von willebrand's disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - eftrenonacog alfa 2000 [iu];   - powder for infusion - 2000 iu - active: eftrenonacog alfa 2000 [iu]   excipient: histidine mannitol polysorbate 20 sucrose sodium chloride water for injection - alprolix is a long-acting anti-haemophilic factor (recombinant) indicated in adults and children with haemophilia b (congenital factor ix deficiency) for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis)

European Union - English - EMA (European Medicines Agency)

ge healthcare as - perflutren - echocardiography - contrast media - this medicinal product is for diagnostic use only.optison is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers, enhance left-ventricular-endocardial-border delineation with resulting improvement in wall-motion visualisation.optison should only be used in patients where the study without contrast enhancement is inconclusive.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sipcam pacific australia pty. limited - diflufenican - suspension concentrate - diflufenican anilide/aniline-nicotinanilide active 500.0 g/l - herbicide - clover pasture | field pea | lentil | lupin | poppy oilseed | drug poppy | oilseed poppy | opium poppy | pulse | subterranean cl - amsinckia - suppression | capeweed - suppression | charlock | chickweed - suppression | corn gromwell - suppression | crassula - suppression | deadnettle | hedge or wild mustard | hyssop loosestrife - suppression | indian hedge mustard | marshmallow - suppression | mouse-ear chickweed - suppression | night-scented stock - suppression | paterson's curse - suppression | pheasant's-eye or adonis | prickly lettuce | rough poppy - suppression | shepherd's purse - suppression | skeleton weed - suppression | sorrel - suppression | speedwell (v. hederifolia) - suppression | stinging nettle - suppression | toad rush - suppression | turnip weed | wild radish or radish weed | wild turnip - brassica tournefortii | wireweed, hogweed - suppression | adonis annua | adonis dentatus | brassica kaber | brassica sinapistrum | buglossoides arvense | crambling mustard | giant mustard | hedge mustard | henbit deadnettle | iron weed | ivyleaf speedwell | ivyleaved speedwell | jointed charlock | knotweed | marsh mallow | mouse-eared

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - damoctocog alfa pegol, quantity: 2000 iu - injection, powder for - excipient ingredients: glycine; histidine; sucrose; calcium chloride dihydrate; sodium chloride; polysorbate 80 - jivi, damoctocog alfa pegol, is a long-acting recombinant factor viii concentrate indicated for use in previously treated adults and adolescents (12 years of age and older) with haemophilia a for:,? routine prophylactic treatment to prevent or reduce the frequency of bleeding episodes,? on-demand treatment and control of bleeding episodes,? per-operative management of bleeding (surgical prophylaxis),jivi does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand?s disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - octocog alfa, quantity: 2000 iu - injection, diluent for - excipient ingredients: water for injections - advate is indicated for use in haemophilia a for prevention and control of haemorrhagic episodes. patients with haemophilia a may be treated with advate as perioperative management. advate is not indicated in von willebrand's disease.